{"prompt": "['OSTPDL1', 'Page 16 of 60', 'parent-reported quality of life measures using the EORTO QLQ-C30', 'questionnaire; results have not yet been reported. 79 Repeated quality of', 'life measurements that are linked to specific clinical indicators may result', 'in more clinically useful and interpretable findings. Furthermore, little to', 'no data exist examining health-related quality of life measures in', 'patients with recurrent osteosarcoma. Better understanding of HRQOL', 'outcomes may identify opportunities to improve treatment-related', 'morbidities, facilitate decision making, establish effective communication', 'strategies and improve satisfaction with care for patients and their', 'families. 80,81 In the setting of a disease which has previously', 'demonstrated poor prognosis after progression or recurrence, HRQOL', 'measures may aid in the identification of reasonable therapeutic', \"approaches that allow for optimization of patients' quality of life in\", 'balance with treatment goals.', 'St. Jude', 'IRB NUMBER: Pro00006856', 'Revision 1.1, dated: 01-19-2018', 'IRB approved: 01-26-3018 APPROVAL DATE: 06/26/2019', 'Protocol document dated: 01-19-2018']['OSTPDL1', 'Page 17 of 60', '2.7.1 Patient Reported Outcome Measurement Information System', '(PROMIS) - Pediatric and Adult Profiles', 'The PROMIS is a set of questionnaires utilized to assess patient reported', 'outcomes (PROs) consistent with goals established by the National', 'Institute of Health (NIH). The PROMIS Pediatric Profile (self-report) is', 'validated for use with individuals ages 8 to 17 years, and the PROMIS', 'Adult Profile (self-report) is validated for individuals ages 18 years and', 'older. Both the PROMIS Pediatric and Adult Profiles include PROs across a', 'number of domains including: 1) physical function mobility, 2) anxiety, 3)', 'depressive symptoms, 4) fatigue, 5) peer relationships, and 6) pain', 'interference. On domains other than the physical function mobility', 'domain, respondents rate how often statements describe their', 'functioning. For the physical function mobility domain, participants use a', '5-point Likert rating scale to rate how much difficulty is experienced with', 'engagement in various activities. Scoring tables are then used to convert', 'raw scores for each domain into age-normed T-scores. The PROMIS', 'measures have demonstrated strong psychometric properties. 82', 'Literature is available for its use in pediatric oncology research, 83,84', 'as', 'well as in adults with lower extremity bone metastases. 85 The PROMIS', 'measures have shown known-group validity with ability to distinguish', 'subgroups of children with a chronic health condition from other', 'conditions as well as general population samples. 86,87 Additionally, the', 'ability to determine a clinical minimally important difference has been', 'established with the PROMIS questionnaires, which has been a', 'methodological limitation of other HRQOL instruments. 88', 'Patients will complete the PROMIS Pediatric or Adult Profile (based on', 'their age at time of administration) at four time points during the study:', 'at diagnosis prior to the start of treatment, at the end of cycle 2 (8 weeks', '+ 1 week), at the end of cycle 4 (16 weeks + 1 week), and at end of', 'avelumab therapy. Mixed effect models will be performed to assess', 'changes in quality of life domains over time and to assess for impact of', 'clinical factors on scores in quality of life domains.', '3.0', 'ELIGIBILITY CRITERIA AND STUDY ENROLLMENT', 'According to institutional and NIH policy, the study will accession', 'research participants regardless of gender and ethnic background.', 'Institutional experience confirms broad representation in this regard.', 'All clinical and laboratory studies to determine eligibility must be', 'performed within 7 days prior to enrollment unless otherwise indicated.', 'Laboratory values used to assess eligibility must be no older than 7 days', 'at the start of therapy. If a post-enrollment lab value is outside the limits', 'of eligibility, or laboratory values are > 7 days old, then the following', 'laboratory evaluations must be re-checked within 48 hours prior to', 'St. Jude', 'IRB NUMBER: Pro00006856', 'Revision 1.1, dated: 01-19-2018', 'IRB approved: 01-26-201 APPROVAL DATE: 06/26/2019', 'Protocol document dated: 01-19-2018']['OSTPDL1', 'Page 18 of 60', 'initiating therapy: CBC with differential, bilirubin, ALT (SGPT) and serum', 'creatinine. Imaging studies, where applicable, must be obtained within 2', 'weeks prior to enrollment.', 'St. Jude', 'IRB NUMBER: Pro00006856', 'Revision 1.1, dated: 01-19-2018', 'IRB approved: DATE: 06/26/2019', 'Protocol document dated: 01-19-2018']\n\n###\n\n", "completion": "END"}